Nahdi Medical Company (TADAWUL:4164)

Saudi Arabia · Delayed Price · Currency is SAR

91.15

-0.15 (-0.16%)

Jul 23, 2026, 3:15 PM AST

-28.62% (1Y)

Market Cap	11.85B -28.6%
Revenue (ttm)	10.37B +5.6%
Net Income	811.26M -3.8%
EPS	6.24 -3.8%
Shares Out	130.00M
PE Ratio	14.61
Forward PE	13.97
Dividend	5.60 (6.14%)
Ex-Dividend Date	Mar 30, 2026

Volume	79,766
Open	92.50
Previous Close	91.30
Day's Range	90.80 - 92.50
52-Week Range	89.75 - 132.10
Beta	0.13
Analysts	Buy
Price Target	124.21 (+36.27%)
Earnings Date	Aug 2, 2026

About Nahdi Medical Company

Nahdi Medical Company, together with its subsidiaries, engages in the wholesale and retail trading of cosmetics, pharmaceutical, special and healthy foods, and medical equipment products in the Kingdom of Saudi Arabia and the United Arab Emirates. The company also offers mom and baby, beauty, and everyday essentials through retail and online stores. In addition, it operates Nahdi Care polyclinic; and provides virtual care services. Further, the company is involved in operating E-Pharmacist platform; and Nahdi Online, an online pharmacy. Additio... [Read more]

Industry Medical - Pharmaceuticals

Sector Healthcare

Founded 1986

Employees 6,182

Stock Exchange Saudi Stock Exchange

Ticker Symbol 4164

Full Company Profile

Financial Performance

In 2025, Nahdi Medical Company's revenue was 10.21 billion, an increase of 8.12% compared to the previous year's 9.45 billion. Earnings were 830.74 million, an increase of 1.22%.

Financial Statements

Analyst Summary

According to 9 analysts, the average rating for 4164 stock is "Buy." The 12-month stock price target is SAR 124.21, which is an increase of 36.27% from the latest price.

Price Target

SAR 124.21

(36.27% upside)

Analyst Consensus: Buy

Stock Forecasts